Yunnan Jianfeng new building materials project is included in the list of major projects in Yunnan province
Release time:
2023-03-14
Yunnan Jianfeng New Building Materials Project covers new environmentally friendly high-performance stone series, new environmentally friendly special dry powder mortar series, green building aggregate and other related modern new building materials. The remaining secondary materials are used for machine-made sand production, and the waste materials will be provided to downstream cement enterprises for use, giving full play to the comprehensive utilization of resources. The total construction land area of the project is about 1500 mu, the total construction area is about 200000 square meters, and the construction scale is 5 million tons per year.
The project is designed in accordance with the standards of green factories from ore mining, plant construction, supporting facilities and equipment, etc., introducing advanced equipment and technology, large-scale development, factory production, and fully enclosed layout to achieve development in protection. Utilizing in development, adhering to the zero-emission, pollution-free production and processing mode, not only improves production efficiency, but also greatly improves various indicators such as environmental protection and resource utilization. At the same time, the project put into operation can also solve the employment of more than 150 people.
According to the requirements of hierarchical and classified management of major projects in Yunnan Province, the annual provincial major projects will be managed and promoted by the people's governments of each state (city) in accordance with the principle of territoriality, the provincial industry authorities are responsible for guiding and dispatching, and the investment authorities Coordinate; states (cities) and departments must strengthen project service guarantees, fully support the handling of major project preliminary requirements, innovate and promote the reform of the approval system, streamline the examination and approval process; give priority to the budgetary funds to support the preliminary work of the project, continue to increase the efforts to strive for all kinds of funds in the central budget and local government special bonds, and coordinate financial funds with market financing to ensure the demand for project funds; all factor guarantee departments should strengthen the overall coordination of factor resource guarantee in accordance with the principle of "elements follow the project; the Provincial Development and Reform Commission regularly schedules the progress of major projects on the integrated project management platform of Yunnan Province, and holds state (city) and departmental scheduling meetings to accelerate the transformation of projects, promote the early implementation of major projects, and give full play to benefits, so as to provide high-quality leap-forward development in Yunnan Province. Inject strong momentum.
At present, Yunnan Jianfeng is going through the approval procedures in accordance with the relevant requirements of the Yunnan Provincial Development and Reform Commission, and will start the project construction work after the procedures are completed. (Reporter Ni Yingzhen)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31